DAVID THEOBALD: Open Payments
NPI 1588003859 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,332 in 71 payments from 16 companies in 2025. Trend: 2023 $35 · 2024 $278 · 2025 $1,332
Food & beverage: $1,332
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $330 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $139 |
| Lilly USA, LLC | 12 | $132 |
| Novo Nordisk Inc | 6 | $107 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $94 |
| Amgen Inc. | 5 | $87 |
| GlaxoSmithKline, LLC. | 4 | $86 |
| Sumitomo Pharma America, Inc. | 3 | $76 |
| Otsuka America Pharmaceutical, Inc. | 3 | $67 |
| ABBVIE INC. | 3 | $55 |
Products named: JARDIANCE, FARXIGA, AIRSUPRA, MOUNJARO, Kerendia, AREXVY, GEMTESA, BREZTRI.
Industry payments across GA — which companies pay providers there.
